PHASE II STUDY OF INTERMITTENT ERLOTINIB (E) PLUS CARBOPLATIN (C), PACLITAXEL (P) AND BEVACIZUMAB (B) AS FRONTLINE TREATMENT OF PATIENTS (PTS) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC): AVAFAST STUDY

被引：0
|
作者：
Cobo Dols, Manuel A. [1 ]
Blanco, Esperanza [2 ]
Bernabe, Reyes [3 ]
Fernandez, Inmaculada [4 ]
Inoriza, Angel [5 ]
Laura Ortega, Ana [6 ]
Valdivia, Javier [7 ]
机构：
[1] Hru Carlos Haya, Malaga, Spain
[2] Hosp Infanta Cristina, Badajoz, Spain
[3] Hosp Nuestra Senora De Valme, Seville, Spain
[4] Hosp De Jerez, Cadiz, Spain
[5] Hosp Juan Ramon Jimenez, Huelva, Spain
[6] Complejo Hosp De Jaen, Jaen, Spain
[7] Hosp Univ Virgen Nieves, Granada, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
ADVANCED NSCLC; Intermittent Erlotinib; Clinical Trial in Progress;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.11-052
引用
收藏
页码：S1213 / S1213
页数：1
相关论文
共 50 条
  • [11] Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study
    Giaccone, Giuseppe
    Ruiz, Marielle Gallegos
    Le Chevalier, Thierry
    Thatcher, Nick
    Smit, Egbert
    Rodriguez, Jose Antonio
    Janne, Pasi
    Oulid-Aissa, Dalila
    Soria, Jean-Charles
    CLINICAL CANCER RESEARCH, 2006, 12 (20) : 6049 - 6055
  • [12] Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer
    Yokoi, Takashi
    Torii, Yoshitaro
    Katashiba, Yuichi
    Sugimoto, Hiroyuki
    Tanijiri, Tsutomu
    Ogata, Makoto
    Inagaki, Noriko
    Kibata, Kayoko
    Hayashi, Mina
    Niki, Maiko
    Shimizu, Toshiki
    Miyara, Takayuki
    Kurata, Takayasu
    Nomura, Shosaku
    ONCOLOGY LETTERS, 2014, 8 (06) : 2453 - 2457
  • [13] A phase II first line study of gemcitabine, carboplatin and bevacizumab in advanced stage non-squamous non-small cell lung cancer
    Clement-Duchene, Christelle
    Krupitskaya, Yelena
    Ganjoo, Kristen
    Lavori, Philip
    Kumar, Atul
    Zhao, Gary
    Padda, Sukhami
    San Pedro-Salcedo, Melanie
    Wakelee, Heather
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S674 - S674
  • [14] A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer
    Yoshida, Hironori
    Kim, Young Hak
    Sakamori, Yuichi
    Nagai, Hiroki
    Ozasa, Hiroaki
    Kaneda, Toshihiko
    Yoshioka, Hiroshige
    Nakagawa, Hiroaki
    Tomii, Keisuke
    Okada, Asuka
    Yoshimura, Kenichi
    Hirabayashi, Masataka
    Hirai, Toyohiro
    ANTICANCER RESEARCH, 2020, 40 (05) : 2981 - 2987
  • [15] A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
    S. Verma
    S. Chitikela
    V. Singh
    S. Khurana
    D. Pushpam
    D. Jain
    S. Kumar
    Y. Gupta
    P. S. Malik
    Medical Oncology, 40
  • [16] A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
    Verma, S.
    Chitikela, S.
    Singh, V.
    Khurana, S.
    Pushpam, D.
    Jain, D.
    Kumar, S.
    Gupta, Y.
    Malik, P. S.
    MEDICAL ONCOLOGY, 2023, 40 (07)
  • [17] Phase II study comparing paclitaxel-carboplatin alone with paclitaxel-carboplatin plus bevacizumab in previously untreated Japanese patients with advanced-stage non-squamous non-small cell lung cancer (NSCLC)
    Asahina, Hajime
    Kunitoh, Hideo
    Ichinose, Yukito
    Horai, Takeshi
    Nishiwaki, Yutaka
    Hida, Toyoaki
    Yamamoto, Nobuyuki
    Kawahara, Masaaki
    Saijo, Nagahiro
    Fukuoka, Masahiro
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S285 - S285
  • [18] NEJ016: Phase II study of carboplatin and weekly paclitaxel plus bevacizumab followed by bevacizumab for highly selected elderly non-squamous non-small cell lung cancer patients
    Harada, T.
    Miura, S.
    Maemondo, M.
    Iwashima, A.
    Sugawara, S.
    Kobayashi, K.
    Inoue, A.
    Nakagawa, T.
    Takiguchi, Y.
    Watanabe, H.
    Seike, M.
    Ishida, T.
    Terada, M.
    Gemma, A.
    Yoshizawa, H.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S617 - S617
  • [19] Phase II study of carboplatin, docetaxel and bevacizumab for chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer
    Yuichi Takiguchi
    Shunichiro Iwasawa
    Koichi Minato
    Yosuke Miura
    Akihiko Gemma
    Rintaro Noro
    Kozo Yoshimori
    Masato Shingyoji
    Mitsunori Hino
    Masahiro Ando
    Hiroaki Okamoto
    International Journal of Clinical Oncology, 2015, 20 : 659 - 667
  • [20] Utility of atezolizumab plus bevacizumab, carboplatin, and paclitaxel combination for the treatment of advanced non-squamous non-small cell lung cancer patients with malignant pleural effusion
    Hisakane, Kakeru
    Atsumi, Kenichiro
    Seike, Masahiro
    Hirose, Takashi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (09)
12345